Hao W - Search Results

1

Ligand-modified homologous targeted cancer cell membrane biomimetic nanostructured lipid carriers for glioma therapy.

Chen M, Cui Y, Hao W, Fan Y, Zhang J, Liu Q, Jiang M, Yang Y, Wang Y, Gao C. Chen M, et al. Among authors: hao w. Drug Deliv. 2021 Dec;28(1):2241-2255. doi: 10.1080/10717544.2021.1992038. Drug Deliv. 2021. PMID: 34668811 Free PMC article.

2

Dual-Target Peptide-Modified Erythrocyte Membrane-Enveloped PLGA Nanoparticles for the Treatment of Glioma.

Cui Y, Sun J, Hao W, Chen M, Wang Y, Xu F, Gao C. Cui Y, et al. Among authors: hao w. Front Oncol. 2020 Oct 21;10:563938. doi: 10.3389/fonc.2020.563938. eCollection 2020. Front Oncol. 2020. PMID: 33194638 Free PMC article.

3

Carrier-free highly drug-loaded biomimetic nanosuspensions encapsulated by cancer cell membrane based on homology and active targeting for the treatment of glioma.

Fan Y, Cui Y, Hao W, Chen M, Liu Q, Wang Y, Yang M, Li Z, Gong W, Song S, Yang Y, Gao C. Fan Y, et al. Among authors: hao w. Bioact Mater. 2021 May 1;6(12):4402-4414. doi: 10.1016/j.bioactmat.2021.04.027. eCollection 2021 Dec. Bioact Mater. 2021. PMID: 33997516 Free PMC article.

4

Cancer Cell Membrane-Coated Nanosuspensions for Enhanced Chemotherapeutic Treatment of Glioma.

Fan Y, Hao W, Cui Y, Chen M, Chu X, Yang Y, Wang Y, Gao C. Fan Y, et al. Among authors: hao w. Molecules. 2021 Aug 23;26(16):5103. doi: 10.3390/molecules26165103. Molecules. 2021. PMID: 34443689 Free PMC article.

5

Hybrid membrane-coated nanosuspensions for multi-modal anti-glioma therapy via drug and antigen delivery.

Hao W, Cui Y, Fan Y, Chen M, Yang G, Wang Y, Yang M, Li Z, Gong W, Yang Y, Gao C. Hao W, et al. J Nanobiotechnology. 2021 Nov 20;19(1):378. doi: 10.1186/s12951-021-01110-0. J Nanobiotechnology. 2021. PMID: 34801032 Free PMC article.

6

[Optimization of formulation of paclitaxel nanosuspension encapsulated by erythrocyte membrane based on Box-Behnken method].

Fan YY, Cui YX, Hao WY, Chen MY, Yang Y, Gao CS. Fan YY, et al. Zhongguo Zhong Yao Za Zhi. 2022 May;47(9):2457-2464. doi: 10.19540/j.cnki.cjcmm.20210409.301. Zhongguo Zhong Yao Za Zhi. 2022. PMID: 35531693 Chinese.

7

Targeted Ferroptosis-Immunotherapy Synergy: Enhanced Antiglioma Efficacy with Hybrid Nanovesicles Comprising NK Cell-Derived Exosomes and RSL3-Loaded Liposomes.

Hao W, Sun N, Fan Y, Chen M, Liu Q, Yang M, Yang Y, Gao C. Hao W, et al. ACS Appl Mater Interfaces. 2024 Jun 5;16(22):28193-28208. doi: 10.1021/acsami.4c04604. Epub 2024 May 22. ACS Appl Mater Interfaces. 2024. PMID: 38776411

8

ROS-responsive biomimetic nanosystem camouflaged by hybrid membranes of platelet-exosomes engineered with neuronal targeting peptide for TBI therapy.

Li Y, Xin X, Zhou X, Liu J, Liu H, Yuan S, Liu H, Hao W, Sun J, Wang Y, Gong W, Yang M, Li Z, Han Y, Gao C, Yang Y. Li Y, et al. Among authors: hao w. J Control Release. 2024 Aug;372:531-550. doi: 10.1016/j.jconrel.2024.06.018. Epub 2024 Jun 28. J Control Release. 2024. PMID: 38851535

9

3D printing-based drug-loaded implanted prosthesis to prevent breast cancer recurrence post-conserving surgery.

Hao W, Zheng Z, Zhu L, Pang L, Ma J, Zhu S, Du L, Jin Y. Hao W, et al. Asian J Pharm Sci. 2021 Jan;16(1):86-96. doi: 10.1016/j.ajps.2020.06.002. Epub 2020 Jul 7. Asian J Pharm Sci. 2021. PMID: 33613732 Free PMC article.

10

PTENα functions as an immune suppressor and promotes immune resistance in PTEN-mutant cancer.

Sun Y, Lu D, Yin Y, Song J, Liu Y, Hao W, Qi F, Zhang G, Zhang X, Liu L, Lin Z, Liang H, Zhao X, Jin Y, Yin Y. Sun Y, et al. Among authors: hao w. Nat Commun. 2021 Aug 26;12(1):5147. doi: 10.1038/s41467-021-25417-6. Nat Commun. 2021. PMID: 34446716 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,713 results

Search Page

Filters